RAD-140 + MK-677 + YK-11 Value Pack
$227.86
This research value pack combines three synthetic compounds frequently studied together in selective receptor and growth signalling pathway research: RAD-140 (Testolone), a non-steroidal selective receptor modulator; MK-677 (Ibutamoren), studied for growth hormone secretagogue properties; and YK-11, studied for its… Research use only | Third-party lab tested.
Buy RAD-140 + MK-677 + YK-11 Value Pack – Swiss Chems USA
RAD-140 + MK-677 + YK-11 Value Pack — Research Overview
This research value pack combines three synthetic compounds frequently studied together in selective receptor and growth signalling pathway research: RAD-140 (Testolone), a non-steroidal selective receptor modulator; MK-677 (Ibutamoren), studied for growth hormone secretagogue properties; and YK-11, studied for its proposed interactions with myostatin-related signalling pathways. Combined research models allow investigation into how selective receptor modulation, growth hormone secretagogue signalling, and myostatin pathway interactions may intersect within body composition and growth-related signalling research. Research applications include comparative selective receptor pathway studies, multi-compound growth signalling research, and experimental protocol design using all three compound classes.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
RAD-140 + MK-677 + YK-11 Value Pack Chemical Properties
| Property | Specification |
|---|---|
| Synonyms | RAD-140 + MK-677 + YK-11 Value Pack |
| Shelf Life | 36 months |
RAD-140 + MK-677 + YK-11 Value Pack Research Applications
This value pack pairs RAD-140 (Testolone), a non-steroidal selective receptor modulator compound studied for specific molecular pathway interactions in experimental models, with MK-677 (Ibutamoren), a synthetic molecule studied for growth hormone secretagogue properties via GHS-R1a receptor engagement and downstream IGF-1 axis signalling, and YK-11, a synthetic steroidal compound studied for its proposed interactions with myostatin-related signalling pathways in muscle cell research models. Combined research protocols examining all three compounds allow investigation into how selective receptor modulation, growth hormone secretagogue signalling, and myostatin pathway interactions may intersect within research models examining body composition and growth-related signalling endpoints. Each compound is independently third-party HPLC-tested; COA available per batch.
RAD-140 + MK-677 + YK-11 Value Pack Frequently Asked Questions
What distinct research pathways does each compound in this value pack address?
RAD-140 is studied for non-steroidal selective receptor modulator activity at androgen receptor binding sites, MK-677 for growth hormone secretagogue properties via GHS-R1a receptor engagement and downstream IGF-1 axis signalling, and YK-11 for proposed interactions with myostatin-related signalling pathways. Combined research protocols allow investigators to examine how these three distinct mechanisms may interact within shared experimental models examining body composition and growth-related signalling.
What experimental models are used to study this combination’s effects on growth-related signalling pathways?
Cell-based receptor binding assays for RAD-140, growth hormone and IGF-1 pathway signalling measurements for MK-677, and myostatin-related gene expression assays (such as follistatin and myostatin pathway markers in myoblast or muscle cell models) for YK-11 are standard methods for studying this three-compound combination, typically compared across single-compound and combined-compound treatment arms relative to vehicle controls.
How should researchers structure comparative protocols using this three-compound value pack?
Factorial or staggered experimental designs incorporating single-compound, paired-compound, and full three-compound treatment arms allow researchers to isolate the contribution of each compound and identify any combination-specific effects on selected receptor and growth signalling endpoints, a standard approach when studying multi-pathway compound combinations.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
Related products
Reviews
There are no reviews yet.